Japan being the second largest pharmaceutical industry in the world, worth $60.3 billion as of 2005, is yet to gain a strong foothold in developing new drugs and in outsourcing. More
The FDA outdid itself last year, granting first-time approvals to 43 new biotech-derived medicines and 36 supplemental indications for drugs and biologics developed by specialty and big pharma companies as well as biotech firms. More
The economic, structural, political and health dynamics that impact growth are rebalancing the worldwide pharmaceutical market, driving global growth of 5-6% for 2007, according to IMS Health. More
Intellectual property rights are essential in today's technology-driven age. Building a strategic IP portfolio is economically important from both an offensive and defensive standpoint. More
Taiwan has a small area of land, small population numbers and limited natural resources. For the past 20 years, although Taiwan has seen high economic growth. More
Biotechnology is an overused term nowadays. Almost any commodity available in the market, will try to brand itself with the value added word: "biotechnology". More
Displaying 1..10 of 84 -
per page
Next page
Order by
All rights reserved. Terms and Conditions | Contact us
